Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases

Glecaprevir/pibrentasvir (G/P) are direct-acting antivirals (DAAs) that achieve a high sustained virological response (SVR) rate for hepatitis C virus (HCV) infection. We investigated G/P effectiveness for HCV patients based on real-world experience and the clinical features of retreatment cases. HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Ayumi, Joshita, Satoru, Yamashita, Yuki, Yamazaki, Tomoo, Fujimori, Naoyuki, Kimura, Takefumi, Matsumoto, Akihiro, Wada, Shuichi, Mori, Hiromitsu, Shibata, Soichiro, Yoshizawa, Kaname, Morita, Susumu, Furuta, Kiyoshi, Kamijo, Atsushi, Iijima, Akihiro, Kako, Satoko, Maruyama, Atsushi, Kobayashi, Masakazu, Komatsu, Michiharu, Matsumura, Makiko, Miyabayashi, Chiharu, Ichijo, Tetsuya, Takeuchi, Aki, Koike, Yuriko, Gibo, Yukio, Tsukadaira, Toshihisa, Inada, Hiroyuki, Nakano, Yoshiyuki, Usuda, Seiichi, Kiyosawa, Kendo, Tanaka, Eiji, Umemura, Takeji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235710/
https://www.ncbi.nlm.nih.gov/pubmed/32260271
http://dx.doi.org/10.3390/biomedicines8040074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235710/
https://www.ncbi.nlm.nih.gov/pubmed/32260271
http://dx.doi.org/10.3390/biomedicines8040074

Ejemplares similares